Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 15.
doi: 10.1038/s41372-025-02257-6. Online ahead of print.

Management of the patent ductus arteriosus among infants born at 23 to 32 weeks' gestation between 2011 to 2022: a report from in the Children's Hospitals Neonatal Consortium

Affiliations

Management of the patent ductus arteriosus among infants born at 23 to 32 weeks' gestation between 2011 to 2022: a report from in the Children's Hospitals Neonatal Consortium

Mark F Weems et al. J Perinatol. .

Abstract

Objective: This study reports on patent ductus arteriosus (PDA) therapy trends across the Children's Hospital Neonatal Consortium.

Study design: We performed a 12-year (2011-2022) retrospective study of premature infants (< 33 weeks) with a PDA. We utilized descriptive statistics to compare demographic, inpatient, and discharge characteristics in 3-year epochs.

Result: From 54,813 infants, 19,843 (36%) had a diagnosis of PDA. Use of pharmacotherapy increased 44% (relative) over time, mostly with increased acetaminophen use. There was a 12.7-fold increase in exposure to multiple PDA medications over the study period. While the rate of definitive closure did not change, use of transcatheter PDA closure increased from 0 to 20.3% and surgical ligation decreased from 25.1% to 3.6%.

Conclusion: There has been an increase in the use of multiple pharmacotherapies for PDA, especially among infants born <27 weeks' gestation. Transcatheter PDA closure has overtaken surgical ligation as the primary method of definitive PDA closure.

PubMed Disclaimer

Conflict of interest statement

Competing interests: MFW is a consultant and speaker for Abbott Congenital Heart for the Piccolo™ PDA Occluder and an associate editor for Pediatrics in Review. RP is a consultant and speaker for Abbott Congenital Heart for the Piccolo™ PDA Occluder. PTL is a speaker for Abbott Congenital Heart for the Piccolo™ PDA Occluder. TRG, KM, and MP are executive members of the Children’s Hospitals Neonatal Consortium, Inc. SHG is on the editorial board of NeoReviews Plus. MKB, IZ, SH, SH, SK, RR, and SS have no competing interests to report. Ethics approval and consent to particiapte: The Stanley Manne Children’s Research Institute’s Institutional Review Board (Chicago, IL) approved de-identified data analysis (identifier: 2011–14673), and each center obtained local regulatory oversight to participate in the CHNC. This study was performed in accordance with the Declaration of Helsinki.

References

    1. Mitra S, Bischoff AR, Sathanandam S, Lakshminrusimha S, McNamara PJ. Procedural closure of the patent ductus arteriosus in preterm infants: a clinical practice guideline. J Perinatol. 2024;44:1402–8.
    1. Gowda SH, Philip R, Weems MF. Obstacles to the early diagnosis and management of patent ductus arteriosus. Res Rep. Neonatol. 2024;2024:43–57.
    1. Shah ZS, Clark RH, Patt HA, Backes CH Jr, Tolia VN. Trends in procedural closure of the patent ductus arteriosus among infants born at 22 to 30 weeks’ gestation. J Pediatr. 2023;263:113716. - DOI - PubMed
    1. Kaluarachchi DC, Rysavy MA, Carper BA, Chock VY, Laughon MM, Backes CH, et al. Secular trends in patent ductus arteriosus management in infants born preterm in the national institute of child health and human development neonatal research network. J Pediatr. 2024;266:113877. - DOI - PubMed
    1. Lai KC, Richardson T, Berman D, DeMauro SB, King BC, Lagatta J, et al. Current trends in invasive closure of patent ductus arteriosus in very low birth weight infants in United States Children’s Hospitals, 2016-2021. J Pediatr. 2023;263:113712. - DOI - PubMed

LinkOut - more resources